Total Joint Arthroplasty in a Pediatric Population
ConditionTotal Joint Arthroplasty
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age10-25
SponsorUniversity of Colorado, Denver
About this trial
The primary purpose of this study is to examine the functional ability and quality of life in those patients who received a total joint arthroplasty (TJA) for reasons other than having a solid tumor at the location of the joint.
Eligibility criteria
Qualifiers
Age between 10 years and 25 years
Undergoing or have undergone total joint arthroplasty at Children's Hospital Colorado for non-solid tumor related reasons
Treated at Children's Hospital Colorado by Dr. Nathan Donaldson, DO or Dr. Steven Thorpe, MD or previously by Travis Heare, MD
Disqualifiers
Subjects and/or parents not capable of completing basic questionnaires in English (HRQL data will not be collected from non-English speaking subjects because we do not have access to versions of these questionnaires that have been validated in languages other than English. These patients may be included at a later date when validated questionnaires are available).
Subjects who underwent hemiarthroplasties, failed rotationplasty to arthroplasty conversions, or joint arthroplasty directly related to a tumor at the location of the joint
Subjects diagnosed with mucopolysaccharidoses (MPS), pseudorheumatoid chondrodysplasia, or diastrophic dwarfism
Age between 10 years and 25 years
Trial design
Treatments tested in this trial
- Not listed
Trial groups
1,000 Participants
are grouped into 4 trial groupsSponsors and collaborators
University of Colorado, Denver
Lead sponsor
National Cancer Institute (NCI)
Collaborator
Source ClinicalTrials.gov